Omnicell Announces XT Amplify, A Multi-Year Innovation Program That Is Intended To Maximize Value For Hospitals, Health Systems, And Post-Acute Care Facilities That Have Invested In Omnicell's XT Automated Dispensing System
Omnicell Announces XT Amplify, A Multi-Year Innovation Program That Is Intended To Maximize Value For Hospitals, Health Systems, And Post-Acute Care Facilities That Have Invested In Omnicell's XT Automated Dispensing System
Omnicell宣佈XT Amplify，這是一項爲期多年的創新計劃，旨在爲投資Omnicell的XT自動配藥系統的醫院、衛生系統和急性後護理機構的價值最大化
Multi-year Innovation Program Designed to Maximize Value and Outcomes for XT Automated Dispensing System
多年創新計劃旨在最大限度地提高 XT 自動點膠系統的價值和成果
Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell" or the "Company"), a leader in transforming the pharmacy care delivery model, today announced XT Amplify, a multi-year innovation program that is intended to maximize value for hospitals, health systems, and post-acute care facilities that have invested in Omnicell's XT Automated Dispensing System while also seeking to drive enhanced clinical and operational outcomes at the points of care and within pharmacies.
藥房護理交付模式的領導者Omnicell, Inc.（納斯達克股票代碼：OMCL）（“Omnicell” 或 “公司”）今天宣佈了XT Amplify，這是一項爲期多年的創新計劃，旨在爲投資Omnicell的XT自動配藥系統的醫院、衛生系統和急性後護理機構實現價值最大化，同時也尋求在醫療點和藥房內部提高臨床和運營結果。
This press release features multimedia. View the full release here:
本新聞稿以多媒體爲特色。在此處查看完整版本：
"We recognize that some of our...
“我們認識到...
登入免費觀看全文
登入/註冊